Best Practice & Research Clinical Anaesthesiology
Volume 24, Issue 1 , Pages 15-25 , March 2010

New insights into acute coagulopathy in trauma patients

  • Michael T. Ganter, MD, DEAA

      Affiliations

    • Privatdozent of Anesthesiology, Institute of Anesthesiology, University Hospital Zurich, Raemistrasse 100, CH–8091 Zurich, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41 44 255 1111; Fax: +41 44 255 4409.
    • ,
  • Jean–François Pittet, MD

      Affiliations

    • Professor of Anesthesiology and Surgery, Department of Anesthesia and Surgery and the Cardiovascular Research Center, University of California San Francisco, San Francisco General Hospital, San Francisco, CA, USA

References 

  1. Injury Chart Book , World Health Organization . Available at: http://www who int/violence_injury_prevention/publications/other_injury/chartb/en/index html 2002[accessed 11.04.2009]
  2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS medicine. 2006;3:e442
  3. Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a reassessment. The Journal of Trauma. 1995;38:185–193
  4. Shackford SR, Mackersie RC, Holbrook TL, et al. The epidemiology of traumatic death. A population–based analysis. Archives of Surgery. 1993;128:571–575
  5. Schreiber MA. Damage control surgery. Critical Care Clinics. 2004;20:101–118
  6. Gando S, Nanzaki S, Kemmotsu O. Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma: application of clinical decision analysis. Annals of Surgery. 1999;229:121–127
  7. Esmon CT. The interactions between inflammation and coagulation. British Journal of Haematology. 2005;131:417–430
  8. Silverboard H, Aisiku I, Martin GS, et al. The role of acute blood transfusion in the development of acute respiratory distress syndrome in patients with severe trauma. The Journal of Trauma. 2005;59:717–723
  9. Charles A, Shaikh AA, Walters M, et al. Blood transfusion is an independent predictor of mortality after blunt trauma. The American Surgeon. 2007;73:1–5
  10. Brohi K, Singh J, Heron M, et al. Acute traumatic coagulopathy. The Journal of trauma. 2003;54:1127–1130
  11. Murray GD, Butcher I, McHugh GS, et al. Multivariable prognostic analysis in traumatic brain injury: results from the IMPACT. Journal of Neurotrauma. 2007;24:329–337
  12. MacLeod JB, Lynn M, McKenney MG, et al. Early coagulopathy predicts mortality in trauma. The Journal of Trauma. 2003;55:39–44
  13. Maegele M, Lefering R, Yucel N, et al. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury. 2007;38:298–304
  14. Brohi K, Cohen MJ, Ganter MT, et al. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway?. Annals of Surgery. 2007;245:812–818
  15. Ho AM, Karmakar MK, Dion PW. Are we giving enough coagulation factors during major trauma resuscitation?. American Journal of Surgery. 2005;190:479–484
  16. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. The Journal of Trauma. 2007;63:805–813
  17. Dente CJ, Shaz BH, Nicholas JM, et al. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. The Journal of Trauma. 2009;66:1616–1624
  18. Zink KA, Sambasivan CN, Holcomb JB, et al. A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. American Journal of Surgery. 2009;197:565–570
  19. Spahn DR, Cerny V, Coats TJ, et al. Management of bleeding following major trauma: a European guideline. Critical Care (London, England). 2007;11:R17
  20. Rossaint R, Cerny V, Coats TJ, et al. Key issues in advanced bleeding care in trauma. Shock. 2006;26:322–331
  21. Theusinger OM, Spahn DR, Ganter MT. Transfusion in trauma: why and how should we change our current practice?. Current Opinion in Anaesthesiology. 2009;22:305–312
  22. Armand R, Hess JR. Treating coagulopathy in trauma patients. Transfusion Medicine Reviews. 2003;17:223–231
  23. Chesebro BB, Rahn P, Carles M, et al. Increase in activated protein C mediates acute traumatic coagulopathy in mice. Shock. 2009;in press
  24. Tieu BH, Holcomb JB, Schreiber MA. Coagulopathy: its pathophysiology and treatment in the injured patient. World Journal of Surgery. 2007;31:1055–1064
  25. Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma: a review of mechanisms. The Journal of Trauma. 2008;65:748–754
  26. Esmon CT. The protein C pathway. Chest. 2003;124:26S–32S
  27. Rezaie AR. Vitronectin functions as a cofactor for rapid inhibition of activated protein C by plasminogen activator inhibitor–1. Implications for the mechanism of profibrinolytic action of activated protein C. The Journal of Biological Chemistry. 2001;276:15567–15570
  28. Niles SE, McLaughlin DF, Perkins JG, et al. Increased mortality associated with the early coagulopathy of trauma in combat casualties. The Journal of Trauma. 2008;64:1459–1463
  29. Brohi K, Cohen MJ, Ganter MT, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. The Journal of Trauma. 2008;64:1211–1217
  30. Bajzar L, Nesheim ME, Tracy PB. The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI–dependent. Blood. 1996;88:2093–2100
  31. Bajzar L, Jain N, Wang P, et al. Thrombin activatable fibrinolysis inhibitor: not just an inhibitor of fibrinolysis. Critical Care Medicine. 2004;32:S320–S324
  32. Binette TM, Taylor FB, Peer G, et al. Thrombin–thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon. Blood. 2007;110:3168–3175
  33. Hrafnkelsdottir T, Erlinge D, Jern S. Extracellular nucleotides ATP and UTP induce a marked acute release of tissue–type plasminogen activator in vivo in man. Thrombosis and Haemostasis. 2001;85:875–881
  34. Di CE. Thrombin interactions. Chest. 2003;124:11S–17S
  35. Sinisalo J, Syrjala M, Mattila KJ, et al. Endothelial release of tissue–type plasminogen activator and ischemia–induced vasodilatation are linked in patients with coronary heart disease. Blood Coagulation & Fibrinolysis. 1999;10:181–187
  36. Osterlund B, Andersson B, Haggmark S, et al. Myocardial ischemia induces coronary t–PA release in the pig. Acta anaesthesiologica Scandinavica. 2002;46:271–278
  37. Dhall TZ, Shah GA, Ferguson IA, et al. Fibrin network structure: modification by platelets. Thrombosis and Haemostasis. 1983;49:42–46
  38. Fosse E, Pillgram–Larsen J, Svennevig JL, et al. Complement activation in injured patients occurs immediately and is dependent on the severity of the trauma. Injury. 1998;29:509–514
  39. Hecke F, Schmidt U, Kola A, et al. Circulating complement proteins in multiple trauma patients––correlation with injury severity, development of sepsis, and outcome. Critical Care Medicine. 1997;25:2015–2024
  40. Ganter MT, Brohi K, Cohen MJ, et al. Role of the alternative pathway in the early complement activation following major trauma. Shock. 2007;28:29–34
  41. McMullen ME, Hart ML, Walsh MC, et al. Mannose–binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo. Immunobiology. 2006;211:759–766
  42. Markiewski MM, Nilsson B, Ekdahl KN, et al. Complement and coagulation: strangers or partners in crime?. Trends in Immunology. 2007;28:184–192
  43. Campbell WD, Lazoura E, Okada N, et al. Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N. Microbiology and Immunology. 2002;46:131–134
  44. Esmon CT. Crosstalk between inflammation and thrombosis. Maturitas. 2008;61:122–131
  45. Zehtabchi S, Soghoian S, Liu Y, et al. The association of coagulopathy and traumatic brain injury in patients with isolated head injury. Resuscitation. 2008;76:52–56
  46. Kunz F, Hortnagl H, Kroesen G, et al. Plasma lipids, coagulation factors, and fibrin formation after severe multiple trauma, and in adult respiratory distress syndrome. The Journal of Trauma. 1978;18:115–120
  47. Levi M, Ten Cate H. Disseminated intravascular coagulation. The New England Journal of Medicine. 1999;341:586–592
  48. Stein SC, Smith DH. Coagulopathy in traumatic brain injury. Neurocritical Care. 2004;1:479–488
  49. Cohen MJ, Brohi K, Ganter MT, et al. Early coagulopathy after traumatic brain injury: the role of hypoperfusion and the protein C pathway. The Journal of Trauma. 2007;63:1254–1261
  50. Gando S, Nanzaki S, Kemmotsu O. Coagulofibrinolytic changes after isolated head injury are not different from those in trauma patients without head injury. The Journal of Trauma. 1999;46:1070–1076
  51. Kushimoto S, Shibata Y, Yamamoto Y. Implications of fibrinogenolysis in patients with closed head injury. Journal of Neurotrauma. 2003;20:357–363
  52. Hauser CJ, Zhou X, Joshi P, et al. The immune microenvironment of human fracture/soft–tissue hematomas and its relationship to systemic immunity. The Journal of Trauma. 1997;42:895–903
  53. Brummel–Ziedins K, Whelihan MF, Ziedins EG, et al. The resuscitative fluid you choose may potentiate bleeding. The Journal of Trauma. 2006;61:1350–1358
  54. de JE, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Critical Care Medicine. 2001;29:1261–1267
  55. Niemi TT, Suojaranta–Ylinen RT, Kukkonen SI, et al. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesthesia and Analgesia. 2006;102:998–1006
  56. Westphal M, James MF, Kozek–Langenecker S, et al. Hydroxyethyl starches: different products––different effects. Anesthesiology. 2009;111:187–202
  57. Velanovich V. Crystalloid versus colloid fluid resuscitation: a meta–analysis of mortality. Surgery. 1989;105:65–71
  58. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ. 1998;316:961–964
  59. Alderson P, Bunn F, Lefebvre C, et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database of Systematic Reviews (Online). 2004;CD001208
  60. Choi PT, Yip G, Quinonez LG, et al. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Critical Care Medicine. 1999;27:200–210
  61. Bunn F, Trivedi D, Ashraf S. Colloid solutions for fluid resuscitation. Cochrane Database of Systematic Reviews (Online). 2008;CD001319
  62. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews (Online). 2007;CD000567
  63. Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. The New England Journal of Medicine. 2004;350:2247–2256
  64. Fenger–Eriksen C, Anker–Moller E, Heslop J, et al. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. British Journal of Anaesthesia. 2005;94:324–329
  65. Treib J, Haass A, Pindur G, et al. Highly substituted hydroxyethyl starch (HES200/0.62) leads to Type–I von Willebrand syndrome after repeated administration. Haemostasis. 1996;26:210–213
  66. Stump DC, Strauss RG, Henriksen RA, et al. Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. Transfusion. 1985;25:349–354
  67. Franz A, Braunlich P, Gamsjager T, et al. The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesthesia and Analgesia. 2001;92:1402–1407
  68. Thaler U, Deusch E, Kozek–Langenecker SA. In vitro effects of gelatin solutions on platelet function: a comparison with hydroxyethyl starch solutions. Anaesthesia. 2005;60:554–559
  69. Fenger–Eriksen C, Tonnesen E, Ingerslev J, et al. Mechanisms of hydroxyethyl starch induced dilutional coagulopathy. Journal of Thrombosis and Haemostasis. 2009;
  70. Fenger–Eriksen C, Jensen TM, Kristensen BS, et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo–controlled clinical trial. Journal of Thrombosis and Haemostasis. 2009;7:795–802
  71. Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma–poor red cell concentrates. Anesthesia and Analgesia. 1995;81:360–365
  72. Fries D, Krismer A, Klingler A, et al. Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. British Journal of Anaesthesia. 2005;95:172–177
  73. Nielsen VG. Colloids decrease clot propagation and strength: role of factor XIII–fibrin polymer and thrombin–fibrinogen interactions. Acta anaesthesiologica Scandinavica. 2005;49:1163–1171
  74. Nielsen VG, Levy JH. Fibrinogen and bleeding: old molecule––new ideas. Anesthesia and Analgesia. 2007;105:902–903
  75. Malone DL, Hess JR, Fingerhut A. Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol. The Journal of Trauma. 2006;60:S91–S96
  76. Reiss RF. Hemostatic defects in massive transfusion: rapid diagnosis and management. American Journal of Critical Care. 2000;9:158–165
  77. Leslie SD, Toy PT. Laboratory hemostatic abnormalities in massively transfused patients given red blood cells and crystalloid. American Journal of Clinical Pathology. 1991;96:770–773
  78. Miller RD. Massive blood transfusions: the impact of Vietnam military data on modern civilian transfusion medicine. Anesthesiology. 2009;110:1412–1416
  79. Broder G, Weil MH. Excess lactate: an index of reversibility of shock in human patients. Science. 1964;143:1457–1459
  80. Abramson D, Scalea TM, Hitchcock R, et al. Lactate clearance and survival following injury. The Journal of Trauma. 1993;35:584–588
  81. Wildenthal K, Mierzwiak DS, Myers RW, et al. Effects of acute lactic acidosis on left ventricular performance. The American Journal of Physiology. 1968;214:1352–1359
  82. Meng ZH, Wolberg AS, Monroe DM, et al. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high–dose factor VIIa in hypothermic and acidotic patients. The Journal of Trauma. 2003;55:886–891
  83. Martini WZ, Dubick MA, Pusateri AE, et al. Does bicarbonate correct coagulation function impaired by acidosis in swine?. The Journal of Trauma. 2006;61:99–106
  84. Martini WZ, Dubick MA, Wade CE, et al. Evaluation of tris–hydroxymethylaminomethane on reversing coagulation abnormalities caused by acidosis in pigs. Critical Care Medicine. 2007;35:1568–1574
  85. Graf H, Leach W, Arieff AI. Evidence for a detrimental effect of bicarbonate therapy in hypoxic lactic acidosis. Science. 1985;227:754–756
  86. American Association of Blood Banks . Technical manual. 18th edn.. Bethesda, MD: Standards for Blood Banks and Transfusion Services; 1998;
  87. Luna GK, Maier RV, Pavlin EG, et al. Incidence and effect of hypothermia in seriously injured patients. The Journal of Trauma. 1987;27:1014–1018
  88. Gregory JS, Flancbaum L, Townsend MC, et al. Incidence and timing of hypothermia in trauma patients undergoing operations. The Journal of Trauma. 1991;31:795–798
  89. Wolberg AS, Meng ZH, Monroe DM, et al. A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. The Journal of Trauma. 2004;56:1221–1228
  90. Martini WZ, Pusateri AE, Uscilowicz JM, et al. Independent contributions of hypothermia and acidosis to coagulopathy in swine. The Journal of Trauma. 2005;58:1002–1009
  91. Frank SM, Beattie C, Christopherson R, et al. Unintentional hypothermia is associated with postoperative myocardial ischemia. The Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology. 1993;78:468–476
  92. Britt LD, Dascombe WH, Rodriguez A. New horizons in management of hypothermia and frostbite injury. The Surgical Clinics of North America. 1991;71:345–370
  93. Brohi K, Cohen MJ, Davenport RA. Acute coagulopathy of trauma: mechanism, identification and effect. Current Opinion in Critical Care. 2007;13:680–685
  94. Riewald M, Ruf W. Protease–activated receptor–1 signaling by activated protein C in cytokine–perturbed endothelial cells is distinct from thrombin signaling. The Journal of Biological Chemistry. 2005;280:19808–19814
  95. Nick JA, Coldren CD, Geraci MW, et al. Recombinant human activated protein C reduces human endotoxin–induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood. 2004;104:3878–3885
  96. Cheng T, Liu D, Griffin JH, et al. Activated protein C blocks p53–mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nature Medicine. 2003;9:338–342
  97. Finigan JH, Dudek SM, Singleton PA, et al. Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1–phosphate receptor transactivation. The Journal of Biological Chemistry. 2005;280:17286–17293
  98. Kashuk JL, Moore EE, Millikan JS, et al. Major abdominal vascular trauma––a unified approach. The Journal of Trauma. 1982;22:672–679
  99. Kashuk JL, Moore EE, Johnson JL, et al. Postinjury life threatening coagulopathy: is 1:1 fresh frozen plasma:packed red blood cells the answer?. The Journal of Trauma. 2008;65:261–270
  100. Stahel PF, Moore EE, Schreier SL, et al. Transfusion strategies in postinjury coagulopathy. Current Opinion in Anaesthesiology. 2009;22:289–298

PII: S1521-6896(09)00074-3

doi: 10.1016/j.bpa.2009.09.010

Best Practice & Research Clinical Anaesthesiology
Volume 24, Issue 1 , Pages 15-25 , March 2010

Article Tools

* Image Usage & Resolution